R&D

Boost Beyond Boundaries

Pipeline

Pipeline name
Indications
Development stage
Discovery Lead Opt. Pre-clinical Phase1 Phase2 Phase3
AST-001
Autism Spectrum Disorder
Discovery Lead Opt. Pre-clinical Phase1 Phase2 Phase3
AST-031
ADHD
Discovery Lead Opt. Pre-clinical Phase1 Phase2 Phase3
AST-004
Rett syndrome
Discovery Lead Opt. Pre-clinical Phase1 Phase2 Phase3
AST-035
Glioblastoma
Discovery Lead Opt. Pre-clinical Phase1 Phase2 Phase3
AST-030
Parkinson's disease, Idiopathic pulmonary fibrosis
Discovery Lead Opt. Pre-clinical Phase1 Phase2 Phase3
China Out-licensed (Feb '24)
AST-038
Neurofibromatosis Type I
Discovery Lead Opt. Pre-clinical Phase1 Phase2 Phase3
China Out-licensed (Feb '24)
AST-029
Parkinson's disease
Discovery Lead Opt. Pre-clinical Phase1 Phase2 Phase3
AST-005
Second-Generation ASD Therapy
Discovery Lead Opt. Pre-clinical Phase1 Phase2 Phase3
AST-011
Second-Generation ASD Therapy
Discovery Lead Opt. Pre-clinical Phase1 Phase2 Phase3